Pharmacotherapy

oncology
pain
dependence
respiratory-tract

Chemotherapy – promising results in the fight against tumour cells

In chemotherapy (or cytostatic therapy), tumour cells are treated with chemotherapeutics that effectively fight tumour cells. In addition, various medications are used to inhibit tumour growth. The medications (cytostatic agents) should attack the malignant cells and kill or destroy them as completely as possible.

In addition to intravenous chemotherapy, it is now possible to take substances orally. Intravenous chemotherapy (systemic chemotherapy) is a form of long-term treatment that acts on the entire body, which is desirable in the case of malignant lymphoma, chronic lymphocytic leukaemia, and multiple myeloma.

The implementation of chemotherapy

Chemotherapy can be performed on either an outpatient or an inpatient basis. The decision depends on the circumstances i.e. the stage of the disease, the general condition of the patient, and the medication used.

Actively fighting against cancer cells

In intravenous chemotherapy, the active agents are transported throughout the entire body via the bloodstream. The cancer cells are thereby systematically killed. Chemotherapeutic agents are particularly effective against metabolically active cells (i.e. cancer cells that frequently divide). Because the healthy cells of different organ systems also divide and multiply, these also respond to the chemotherapy. In the patient, this manifests as side effects and complications: Nausea/vomiting, diarrhoea, temporary hair loss, and the deterioration of human organs and tissue. The physician will discuss possible side effects with the patient and may prescribe other medications to relieve them.

Long-term therapy

Chemotherapy consists of several individual treatments that are performed at specific intervals. The dosages of the medication and the periods between treatments are precisely calculated. Examinations will be performed in between treatments in order to determine whether the treatment is working i.e. whether the tumour cells are regressing.

Involvement and innovation

Mundipharma has been committed to the quality of life of lymphoma patients for many years. Mundipharma is a provider of innovative substances for the treatment of different haemato-oncological diseases. Mundipharma also provides numerous pain-relief medications for cancer patients.

Articles on the Subject:

This text is for your general information only. Please consult a physician or pharmacist if you have any complaints or questions about the products.